Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Comment by LakeOromoctoon Jul 13, 2020 2:33pm
142 Views
Post# 31261613

RE:RE:RE:Interesting article- immunity response

RE:RE:RE:Interesting article- immunity response Thanks for the articile.  I have also been in contact with Sirona and they are making headway with the anti viral program in France. I believe Geraldine is talented enough to make a contribution to this global problem. of course this could take a long time but this covid problem is not going away any time soon. I appreciate people like Wexworth adding positive views on our stock/company.
Sirona is a determined group and now we are finally seeing this penny stock starting up the ladder to become a solid company.  
If you have short vision then maybe this isnt the stock for you. keep in mind there is a group of us that own millions of shares and we are still at the table.
thanks .

Bullboard Posts